Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie: Therapie des Typ-2-Diabetes. S3-Leitlinie. AWMF-Registernr.: nvl-001g. 2023.
Gnesin F, Thuesen AC, Kahler LK et al. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2020; (6): CD012906.
Health Information and Quality Authority (HIQA). Health Technology Assessment of Metabolic Surgery for the Treatment of Comorbid Type 2 Diabetes and Obesity. 2022.
Landgraf R, Aberle J, Birkenfeld AL et al. Therapy of Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2019; 127(S 01): S73-S92.
Naude CE, Brand A, Schoonees A et al. Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk. Cochrane Database Syst Rev 2022; (1): CD013334.
Semlitsch T, Engler J, Siebenhofer A et al. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2020; (11): CD005613.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.